Recent news on Naltrexone Hydrochloride

Elite Pharmaceuticals Provides Positive Clinical Update  -  Feb 16, 2007
PipelineReview.com (press release),This study was designed to determine the optimal ratio of oxycodone hydrochloride and opioid antagonist, naltrexone hydrochloride, to significantly block

Kadian not affected by alcohol  -  Feb 9, 2007
United Press InternationalThe subjects were given oral naltrexone hydrochloride 12 and two hours prior to treatment to counter the morphine effects, since morphine and alcohol can be

Alpharma Data Demonstrates Alcohol Does Not Significantly Affect ...  -  Feb 10, 2007
Medical News Today (press release),Oral naltrexone hydrochloride was administered 12 hours and 2 hours prior to treatment to counter morphine effects. There were no serious adverse events

Elite Holds Clinical Guidance Meeting with the FDA on Its Abuse ...  Oct 27, 2006
ELI-216 is a controlled-release oxycodone hydrochloride agonist combined with an opioid antagonist, naltrexone hydrochloride, formulated to deter abuse of the ... -Genetic Engineering News (press release), Elite Meets with FDA for Guidance  Oct 27, 2006
The drug uses a controlled release of its active ingredient, oxycodone hydrochloride, together with naltrexone hydrochloride, which reverses the effects of ... -Business New Jersey (subscription), Elite Pharmaceuticals Receives Approval from Independent Review ...  Sep 6, 2006
...a sustained release formulation intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulated to ... -PharmaLive.com

Elite Pharmaceuticals Provides Update on Company's Progress and ...  Sep 12, 2006
ELI-216 is a combination of a narcotic agonist, oxycodone hydrochloride, and an antagonist, naltrexone hydrochloride, formulated as a controlled release ... -PharmaLive.com

Elite to Participate in Roth Capital's 2006 New York Conference  Aug 31, 2006
...agonist oxycodone hydrochloride, intended for use by patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulated to ... -Business Wire

Elite Pharmaceuticals Gets Independent Approval  Sep 6, 2006
The study is evaluating the efficacy of ELI-216 and the amount of the addiction-stopping chemical - naltrexone hydrochloride - necessary to reduce or eliminate ... -Business New Jersey (subscription)



Elite to Participate in First Albany Capital's Chronic Pain ...  Mar 13, 2006
...agonist oxycodone hydrochloride, intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulated to ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional